Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels
- 1 February 1991
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 55 (2), 272-275
- https://doi.org/10.1016/s0015-0282(16)54114-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Protocols for Induction of Ovulation The Concept of Programmed CyclesAnnals of the New York Academy of Sciences, 1988
- Ovarian Responses in Macaques to Pulsatile Infusion of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone: Increased Sensitivity of the Maturing Follicle to FSH*Endocrinology, 1986
- Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulationFertility and Sterility, 1986
- Comparison of the Potential for Therapeutic Utilities with Gonadotropin-Releasing Hormone Agonists and AntagonistsEndocrine Reviews, 1986
- Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppressionFertility and Sterility, 1986
- Specific binding of luteinizing hormone releasing hormone to human luteal tissueBiochemical and Biophysical Research Communications, 1983